Efg Asset Management (North America) Corp. Avidity Biosciences, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $580 Million
- Q1 2025
A detailed history of Efg Asset Management (North America) Corp. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 155,420 shares of RNA stock, worth $4.53 Million. This represents 0.79% of its overall portfolio holdings.
Number of Shares
155,420
Previous 119,503
30.06%
Holding current value
$4.53 Million
Previous $3.48 Million
32.0%
% of portfolio
0.79%
Previous 0.49%
Shares
4 transactions
Others Institutions Holding RNA
# of Institutions
244Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$333 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$331 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$282 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$269 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$255 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.52B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...